Opioid Settlement Fund Tracking Register After The Purdue Settlement

PROBLEM: A $7.4 billion settlement with Purdue Pharma and its owners, the Sackler family, signed by 55 attorneys general in June 2025 and confirmed by the U.S. Bankruptcy Court (S.D.N.Y.) in November 2025, delivers funds for addiction treatment, prevention and recovery over 15 years and permanently bars the Sacklers from selling opioids in the United States, after the U.S. Supreme Court in June 2024 invalidated an earlier settlement. Without a standing tracking register, multi-year, multi-recipient settlement funds are hard to follow from payment to use.

SOLUTION: An IBM Cloud Ideas compliance register that records each opioid-settlement payment by payer, amount, due date, recipient jurisdiction, and the treatment, prevention or recovery purpose it was allocated to, flagging late or unallocated payments for follow-up.

EVIDENCE BASIS: DOCUMENTED — Multistate attorneys general / California Attorney General, 2025 (settlement effective 2026): $7.4 billion Purdue Pharma / Sackler settlement; 55 attorneys general signed June 2025; U.S. Bankruptcy Court confirmed November 2025; Sacklers barred from selling opioids in the U.S.